PolyPid director reports initial holdings, options

PolyPid Ltd. director Barenholz Yechezkel reports his initial holdings in a Form 3.

Accepted by SEC EDGAR 03/23/2026 - 08:05 AM EDT

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

PolyPid Ltd. director Barenholz Yechezkel reports his initial holdings in a Form 3. The filing shows direct ownership of 2,760 Ordinary Shares and several stock option awards over Ordinary Shares, with exercise prices ranging from $2.6700 to $23.0700 and expirations from 2031 to 2035. Footnotes explain that earlier grants are already fully vested, while a June 25, 2025 grant vests quarterly through May 12, 2029.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Barenholz Yechezkel

Role Director

Type	Security	Shares	Price	Value
Holding	Stock option (right to buy)	--	--	--
Holding	Stock option (right to buy)	--	--	--
Holding	Stock option (right to buy)	--	--	--
Holding	Stock option (right to buy)	--	--	--
Holding	Stock option (right to buy)	--	--	--
Holding	Ordinary Shares	--	--	--

Holdings: Stock option (right to buy) — 21,863 contracts (Direct); Ordinary Shares — 2,760 shares (Direct)

Footnotes (5)

F1. The options were granted on May 5, 2023 and fully vested as of May 5, 2024.
F2. The options were granted on April 13, 2021 and fully vested as of April 13, 2022.
F3. The options were granted on May 3, 2022 and fully vested as of May 3, 2023.
F4. The options were granted on July 2, 2024 and fully vested as of July 2, 2025.
F5. The options were granted on June 25, 2025 and vest on a quarterly basis beginning May 12, 2025 until May 12, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Barenholz Yechezkel’s Form 3 for PolyPid (PYPD) show?

The Form 3 lists Barenholz Yechezkel’s initial ownership in PolyPid, including 2,760 Ordinary Shares held directly and multiple stock option awards over Ordinary Shares with various exercise prices, vesting schedules, and expiration dates extending out to 2035.

How many PolyPid (PYPD) Ordinary Shares does Barenholz hold directly?

Barenholz holds 2,760 PolyPid Ordinary Shares directly as of the Form 3 date. This direct ownership is separate from his stock options, which give rights to acquire additional Ordinary Shares at preset exercise prices in the future.

What stock options over PolyPid (PYPD) shares are reported in this Form 3?

The filing shows several stock option grants over PolyPid Ordinary Shares, with underlying amounts such as 312, 299, 312, 6,500 and 14,440 shares. Exercise prices range from $2.6700 to $23.0700, with expirations between 2031 and 2035.

Are Barenholz’s PolyPid (PYPD) stock options vested?

Footnotes state that options granted on May 5, 2023, April 13, 2021, May 3, 2022 and July 2, 2024 are fully vested. Options granted on June 25, 2025 vest quarterly beginning May 12, 2025 and continue vesting until May 12, 2029.

Does this PolyPid (PYPD) Form 3 show any recent insider buying or selling?

The Form 3 functions as an initial ownership report, listing existing holdings and option awards for Barenholz Yechezkel. The summarized data are categorized as holdings, with no recorded buy or sell transactions in the transaction summary for this filing.

What are the expiration dates of Barenholz’s PolyPid (PYPD) stock options?

Reported option expirations include April 13, 2031, May 3, 2032, May 5, 2033, July 2, 2034 and June 25, 2035. These dates mark the last day each respective stock option grant can be exercised for Ordinary Shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Barenholz Yechezkel

(Last)

(First)

(Middle)

C/O POLYPID LTD.

18 HASIVIM STREET ISRAEL

(Street)

PETACH TIKVA

495376

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
PolyPid Ltd. [ PYPD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	2,760	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock option (right to buy)	08/05/2023	05/05/2033	Ordinary Shares	312⁽¹⁾	$11.4	D
Stock option (right to buy)	07/13/2021	04/13/2031	Ordinary Shares	299⁽²⁾	$23.07	D
Stock option (right to buy)	08/03/2022	05/03/2032	Ordinary Shares	312⁽³⁾	$23.07	D
Stock option (right to buy)	10/02/2024	07/02/2034	Ordinary Shares	6,500⁽⁴⁾	$4.24	D
Stock option (right to buy)	08/12/2025	06/25/2035	Ordinary Shares	14,440⁽⁵⁾	$2.67	D

Explanation of Responses:

1. The options were granted on May 5, 2023 and fully vested as of May 5, 2024.

2. The options were granted on April 13, 2021 and fully vested as of April 13, 2022.

3. The options were granted on May 3, 2022 and fully vested as of May 3, 2023.

4. The options were granted on July 2, 2024 and fully vested as of July 2, 2025.

5. The options were granted on June 25, 2025 and vest on a quarterly basis beginning May 12, 2025 until May 12, 2029.

	/s/ Yechezkel Barenholz	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR